A Multicenter, Open-label, Phase 3 Extension Study to Evaluate the Long-term Efficacy and Safety in Participants Who Are Currently on Treatment in a Belzutifan Study (LITESPARK-043)
A Multicenter, Open-label, Phase 3 Extension Study to Evaluate the Long-term Efficacy and Safety in Participants Who Are Currently on Treatment in a Belzutifan Study (LITESPARK-043)
Researchers are looking for new ways to treat advanced solid tumors and von Hippel-Lindau (VHL)-related tumors:
Researchers want to learn about the long-term effects of a trial medicine called belzutifan. Belzutifan, also called MK-6482, is designed to block a protein that helps tumors grow and survive. This is an extension trial, which means only people who were in certain other belzutifan trials (called parent trials) may be able to join. The goal of this trial is to learn how long people live after they start taking belzutifan.
Inclusion Criteria:
The main inclusion criteria include but are not limited to the following:
Exclusion Criteria:
The main exclusion criteria include but are not limited to the following:
Trialsites@msd.com1-888-577-8839
Boston, Massachusetts 02215, United States
617-667-7000
Philadelphia, Pennsylvania 19104, United States
Kogarah, New South Wales 2217, Australia
São Paulo, São Paulo 01323-001, Brazil
Temuco, Araucania 4800827, Chile
Budapest, 1122, Hungary
Maastricht, Limburg 6229 HX, Netherlands
Amsterdam, North Holland 1066 CX, Netherlands
Bydgoszcz, Kuyavian-Pomeranian Voivodeship 85-796, Poland
Saint Petersburg, Sankt-Peterburg 197758, Russia
Gangnam, Seoul 06351, South Korea
+82-2-3410-1767
Seodaemun-gu, Seoul 03722, South Korea
+82-2-2228-8138
Dnipropetrovsk, Dnipropetrovsk Oblast 49005, Ukraine
Ivano-Frankivsk, Ivano-Frankivsk Oblast 76018, Ukraine
Glasgow, Glasgow City G12 0YN, United Kingdom
London, London, City of SW3 6JJ, United Kingdom
London, London, City of W6 8RF, United Kingdom
617-632-3466
800-527-6266
215-360-0737
615-329-7274
210-593-5265
206-606-7341
+6191133830
+61288908383
+32 (0)16 34 69 12
+56452316296
+56452657374
+56224457254
+56225992900
+56229490970
+56323320861
588441111
+45 38688798
+358331163082
+33368766767
+33531155050
0033142114211
+3612248600 #3162
+97247772688
+97226777333
+97239377377
+972035303030
+ 972 3 6947284
+81-92-641-1151
+31433876400
+31205129111
+31886246040
093074949
+48523743862
+82-2-3010-5977
+34934894350
+34 91 390 83 39
+380505896241
+441413017064
+442072533411
+442087523829
0161 918 7884